ETP-ALL is characterized by an active hematopoietic stem cell renewal program and high expression of LYL1, LMO2, MEF2C, HHEX, and BCL2 (1, 5, 25, 26). The gene discussed is HHEX; the disease is acute lymphoblastic leukemia.